Evaluation of Nonenhancing Tumor Fraction Assessed by Dynamic Contrast-Enhanced MRI Subtraction as a Predictor of Decrease in Tumor Volume in Response to Chemoradiotherapy in Advanced Cervical Cancer

article

Evaluation of Nonenhancing Tumor Fraction Assessed by Dynamic Contrast-Enhanced MRI Subtraction as a Predictor of Decrease in Tumor Volume in Response to Chemoradiotherapy in Advanced Cervical Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2214/AJR.09.3437
P698PubMed publication ID20651213

P50authorJames D BrentonQ30506432
Lorenzo MannelliQ46986804
Martin J. GravesQ47424950
Andrew J PattersonQ50581578
Andrew N. PriestQ50581584
David J LomasQ56613432
Li Tee TanQ71481675
Evis SalaQ89724459
Robin A F CrawfordQ114514037
Mark A ZahraQ114514038
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectcervix uterine cancerQ160105
P304page(s)524-527
P577publication date2010-08-01
P1433published inAmerican Journal of RoentgenologyQ15752879
P1476titleEvaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer
P478volume195

Reverse relations

cites work (P2860)
Q91951036DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
Q39995682DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis
Q47662747Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI.
Q53359183Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
Q38271116Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.
Q28651176Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)
Q37958803Noncontrast functional MRI of the kidneys.
Q38817570Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer
Q35334958Quantitative effects of using compressed sensing in dynamic contrast enhanced MRI
Q53089236Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
Q35786155Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI
Q47769079Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Q90259127Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy